<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-136964</identifier>
<setSpec>1699-258X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Factors associated with sustained remission in patients with rheumatoid arthritis</dc:title>
<dc:description xml:lang="en">Objective. To find out the factors that are associated with sustained remission measured by DAS28 and boolean ACR EULAR 2011 criteria at the time of diagnosis of rheumatoid arthritis. Materials and methods. Medical records of patients with rheumatoid arthritis in sustained remission according to DAS28 were reviewed. They were compared with patients who did not achieved values of DAS28 &lt; 2.6 in any visit during the first 3 years after diagnosis. We also evaluated if patients achieved the boolean ACR/EULAR criteria. Variables analyzed: sex, age, smoking, comorbidities, rheumatoid factor, anti-CCP, ESR, CRP, erosions, HAQ, DAS28, extra-articular manifestations, time to initiation of treatment, involvement of large joints, number of tender joints, number of swollen joints, pharmacological treatment. Results. Forty five patients that achieved sustained remission were compared with 44 controls. The variables present at diagnosis that significantly were associated with remission by DAS28 were: lower values of DAS28, HAQ, ESR, NTJ, NSJ, negative CRP, absence of erosions, male sex and absence of involvement of large joints. Only 24.71% achieved the boolean criteria. The variables associated with sustained remission by these criteria were: lower values of DAS28, HAQ, ESR, number of tender joints and number of swollen joints, negative CRP and absence of erosions. Conclusion. The factors associated with sustained remission were the lower baseline disease activity, the low degree of functional disability and lower joint involvement. We consider it important to recognize these factors to optimize treatment (AU)</dc:description>
<dc:creator>Seccoa, Anastasia</dc:creator>
<dc:creator>Mammani, Marta</dc:creator>
<dc:creator>Marino Claveriea, Lucila</dc:creator>
<dc:creator>Martire, María Victoria</dc:creator>
<dc:creator>Duartea, Vanesa</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo. Hallar factores presentes en el momento del diagnóstico de artritis reumatoide, que se asocian a remisión sostenida medida por DAS28 y criterios booleanos ACR EULAR. Materiales y métodos. Se revisaron historias clínicas de pacientes con artritis reumatoide en remisión sostenida según DAS28. Se compararon con pacientes que no alcanzaron valores de DAS 28 &lt; 2,6 en ninguna visita durante los 3 primeros años desde el diagnóstico. También fueron evaluados si cumplían los criterios ACR/EULAR booleanos. Variables analizadas: sexo, edad al inicio de los síntomas, tabaquismo, comorbilidades, factor reumatoide, anti-CCP, VSG, PCR, erosiones, HAQ, DAS28, manifestaciones extraarticulares, tiempo en iniciar el tratamiento, compromiso de grandes articulaciones, número de articulaciones dolorosas, número de articulaciones tumefactas, tratamiento farmacológico. Resultados. Cuarenta y cinco pacientes que habían alcanzado la remisión sostenida se compararon con 44 controles. Las variables que se asociaron de manera significativa con remisión sostenida por DAS28 fueron: menores valores de DAS28, HAQ, VSG, número de articulaciones dolorosas y número de articulaciones tumefactas, PCR negativa, ausencia de erosiones, sexo masculino y ausencia de compromiso de grandes articulaciones. Solo un 24,71% de los pacientes alcanzaron los criterios booleanos. Las variables que se asociaron a remisión sostenida por estos criterios fueron: menores valores de DAS28, HAQ, VSG, número de articulaciones dolorosas y número de articulaciones tumefactas, PCR negativa y ausencia de erosiones. Conclusión. Los factores asociados a remisión sostenida fueron la menor actividad inflamatoria basal, el bajo grado de discapacidad funcional y el menor compromiso articular. Consideramos relevante reconocer estos factores para optimizar el tratamiento (AU)</dc:description>
<dc:source>Reumatol. clín. (Barc.);11(4): 237-241, jul.-ago. 2015. tab</dc:source>
<dc:identifier>ibc-136964</dc:identifier>
<dc:title xml:lang="es">Factores asociados a remisión sostenida en pacientes con artritis reumatoide</dc:title>
<dc:subject>^d7764^s22032</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d12628</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d24551</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d24572</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d1178^s22016</dc:subject>
<dc:subject>^d22622^s22073</dc:subject>
<dc:subject>^d1174^s22016</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d12438^s22083</dc:subject>
<dc:subject>^d19059</dc:subject>
<dc:subject>^d1174^s22057</dc:subject>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d906^s22073</dc:subject>
<dc:subject>^d7764^s22021</dc:subject>
<dc:subject>^d6531</dc:subject>
<dc:subject>^d7760^s22080</dc:subject>
<dc:subject>^d28603</dc:subject>
<dc:subject>^d308^s22073</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d24584</dc:subject>
<dc:subject>^d53386</dc:subject>
<dc:type>article</dc:type>
<dc:date>201508</dc:date>
</metadata>
</record>
</ibecs-document>
